4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-15-000128
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2015-01-11 | Grant or award · Warrant for Common Stock | +150,000 | 150,000 | I | ||
Loading xslF345X03/form4-01132015_020102.xml…